QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 16, 2005, 25(46):10682-10688; doi:10.1523/JNEUROSCI.1166-05.2005

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (73) Citing Articles via Google Scholar Google Scholar Articles by Dias, R. Articles by Reynolds, D. S. Search for Related Content PubMed PubMed Citation Articles by Dias, R. Articles by Reynolds, D. S.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Evidence for a Significant Role of 3-Containing GABA_A Receptors in Mediating the Anxiolytic Effects of Benzodiazepines

Rebecca Dias, Wayne F. A. Sheppard, Rosa L. Fradley, Elizabeth M. Garrett, Joanna L. Stanley, Spencer J. Tye, Simon Goodacre, Rachael J. Lincoln, Susan M. Cook, Rachel Conley, David Hallett, Alexander C. Humphries, Sally A. Thompson, Keith A. Wafford, Leslie J. Street, J. Luis Castro, Paul J. Whiting, Thomas W. Rosahl, John R. Atack, Ruth M. McKernan, Gerard R. Dawson, and David S. Reynolds

The Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Terlings Park, Harlow, Essex CM20 2QR, United Kingdom

The GABA_A receptor subtypes responsible for the anxiolytic effects of nonselective benzodiazepines (BZs) such as chlordiazepoxide (CDP) and diazepam remain controversial. Hence, molecular genetic data suggest that 2-rather than 3-containing GABA_A receptors are responsible for the anxiolytic effects of diazepam, whereas the anxiogenic effects of an 3-selective inverse agonist suggest that an agonist selective for this subtype should be anxiolytic. We have extended this latter pharmacological approach to identify a compound, 4,2'-difluoro-5'-[8-fluoro-7-(1-hydroxy-1-methylethyl)imidazo[1,2-á]pyridin-3-yl]biphenyl-2-carbonitrile (TP003), that is an 3 subtype selective agonist that produced a robust anxiolytic-like effect in both rodent and non-human primate behavioral models of anxiety. Moreover, in mice containing a point mutation that renders 2-containing receptors BZ insensitive (2H101R mice), TP003 as well as the nonselective agonist CDP retained efficacy in a stress-induced hyperthermia model. Together, these data show that potentiation of 3-containing GABA_A receptors is sufficient to produce the anxiolytic effects of BZs and that 2 potentiation may not be necessary.

Key words: GABA_A; benzodiazepine; anxiety; 3 subunit; agonist; stress-induced hyperthermia

---

Received March 24, 2005; revised October 3, 2005; accepted October 4, 2005.

This article has been cited by other articles:

				J. R. Atack, K. A. Maubach, K. A. Wafford, D. O'Connor, A. D. Rodrigues, D. C. Evans, F. D. Tattersall, M. S. Chambers, A. M. MacLeod, W.-S. Eng, et al. In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA Receptor {alpha}5 Subtype-Selective Inverse Agonist J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 470 - 484. [Abstract] [Full Text] [PDF]

				P. Belujon, J. Baufreton, L. Grandoso, E. Boue-Grabot, T.F.C. Batten, L. Ugedo, M. Garret, and A. I. Taupignon Inhibitory Transmission in Locus Coeruleus Neurons Expressing GABAA Receptor Epsilon Subunit Has a Number of Unique Properties J Neurophysiol, October 1, 2009; 102(4): 2312 - 2325. [Abstract] [Full Text] [PDF]

				J. Bailey, A Papadopoulos, K Seddon, and D. Nutt A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO2 models of experimental human anxiety J Psychopharmacol, March 1, 2009; 23(2): 117 - 122. [Abstract] [PDF]

				F. Jia, P. A. Goldstein, and N. L. Harrison The Modulation of Synaptic GABAA Receptors in the Thalamus by Eszopiclone and Zolpidem J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 1000 - 1006. [Abstract] [Full Text] [PDF]

				N. R. Mirza, J. S. Larsen, C. Mathiasen, T. A. Jacobsen, G. Munro, H. K. Erichsen, A. N. Nielsen, K. B. Troelsen, E. O. Nielsen, and P. K. Ahring NS11394 [3'-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a Unique Subtype-Selective GABAA Receptor Positive Allosteric Modulator: In Vitro Actions, Pharmacokinetic Properties and in Vivo Anxiolytic Efficacy J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 954 - 968. [Abstract] [Full Text] [PDF]

				H. Matsuoka, K. Harada, Y. Endo, A. Warashina, Y. Doi, J. Nakamura, and M. Inoue Molecular mechanisms supporting a paracrine role of GABA in rat adrenal medullary cells J. Physiol., October 15, 2008; 586(20): 4825 - 4842. [Abstract] [Full Text] [PDF]

				R. W. Olsen and W. Sieghart International Union of Pharmacology. LXX. Subtypes of {gamma}-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update Pharmacol. Rev., September 1, 2008; 60(3): 243 - 260. [Abstract] [Full Text] [PDF]

				D. R. Peden, C. M. Petitjean, M. B. Herd, M. S. Durakoglugil, T. W. Rosahl, K. Wafford, G. E. Homanics, D. Belelli, J.-M. Fritschy, and J. J. Lambert Developmental maturation of synaptic and extrasynaptic GABAA receptors in mouse thalamic ventrobasal neurones J. Physiol., February 15, 2008; 586(4): 965 - 987. [Abstract] [Full Text] [PDF]

				S.L. de Haas, S.J. de Visser, J.P. van der Post, R.C. Schoemaker, K. van Dyck, M.G. Murphy, M. de Smet, L.K. Vessey, R. Ramakrishnan, L. Xue, et al. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABAA {alpha}2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers J Psychopharmacol, January 1, 2008; 22(1): 24 - 32. [Abstract] [PDF]

				A. B. Ali Presynaptic Inhibition of GABAA Receptor-Mediated Unitary IPSPs by Cannabinoid Receptors at Synapses Between CCK-Positive Interneurons in Rat Hippocampus J Neurophysiol, August 1, 2007; 98(2): 861 - 869. [Abstract] [Full Text] [PDF]

				R. L. Fradley, M. R. Guscott, S. Bull, D. J. Hallett, S. C. Goodacre, K. A. Wafford, E. M. Garrett, R. J. Newman, G. F. O'Meara, P. J. Whiting, et al. Differential contribution of GABAA receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands J Psychopharmacol, June 1, 2007; 21(4): 384 - 391. [Abstract] [PDF]

				S.L. de Haas, S.J. de Visser, J.P. van der Post, M. de Smet, R.C. Schoemaker, B. Rijnbeek, A.F. Cohen, J.M. Vega, N.G.B. Agrawal, T.V. Goel, et al. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABAA {alpha}2,3 subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers J Psychopharmacol, June 1, 2007; 21(4): 374 - 383. [Abstract] [PDF]

				P. Popik, E. Kostakis, M. Krawczyk, G. Nowak, B. Szewczyk, P. Krieter, Z. Chen, S. J. Russek, T. T. Gibbs, D. H. Farb, et al. The Anxioselective Agent 7-(2-Chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) Is More Efficacious Than Diazepam at Enhancing GABA-Gated Currents at {alpha}1 Subunit-Containing GABAA Receptors J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1244 - 1252. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help